Suresh Babu K resigns as Natco Pharma Vice President
Hyderabad: Natco Pharma has announced that Sri Suresh Babu K, Vice President – Quality Assurance for Chemical Division, Mekaguda of the Company has resigned for pursuing beter prospects."The Company has accepted his resignation and relieved from his duties w.e.f. 15th November, 2023," the Company stated in a BSE filing. Read also: Natco Pharma Pharmacovigilance department...
Hyderabad: Natco Pharma has announced that Sri Suresh Babu K, Vice President – Quality Assurance for Chemical Division, Mekaguda of the Company has resigned for pursuing beter prospects.
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”). The company focuses primarily on niche therapeutic areas and complex products. It markets and distributes products in over 40 countries. It sells FDF products in the United States, India, Europe and the rest of the world (“RoW”). Natco also operates in certain key geographies through its subsidiaries.
Natco Pharma is also engaged in contract manufacturing business, whereby it undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd